Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction

about

Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction

Item

http://www.wikidata.org/entity/Q58130037

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Trastuzumab in Female Breast C ...... Ventricular Ejection Fraction

@en

Trastuzumab in Female Breast C ...... Ventricular Ejection Fraction

@nl

type

Item

label

Trastuzumab in Female Breast C ...... Ventricular Ejection Fraction

@en

Trastuzumab in Female Breast C ...... Ventricular Ejection Fraction

@nl

prefLabel

Trastuzumab in Female Breast C ...... Ventricular Ejection Fraction

@en

Trastuzumab in Female Breast C ...... Ventricular Ejection Fraction

@nl

P1476

Trastuzumab in Female Breast C ...... Ventricular Ejection Fraction

@en

P2093

Hector R Villarraga

http://www.w3.org/2001/XMLSchema#string

Jae Yoon Park

http://www.w3.org/2001/XMLSchema#string

Joerg Herrmann

http://www.w3.org/2001/XMLSchema#string

Kathryn Jean Ruddy

http://www.w3.org/2001/XMLSchema#string

Khaled Aziz

http://www.w3.org/2001/XMLSchema#string

Somaira Nowsheen

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Evaluation and management of patients with heart disease and cancer: cardio-oncology

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Untangling the ErbB signalling network

Cardiac dysfunction in the trastuzumab clinical trials experience

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

P304

e008637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/JAHA.118.008637

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amir Lerman

P577

2018-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30371238

http://www.w3.org/2001/XMLSchema#string

P932

6201446

http://www.w3.org/2001/XMLSchema#string